SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (1040)6/13/2003 10:25:53 AM
From: tuck  Read Replies (1) of 7424
 
ARDM ~22%

>>9:34AM Punk Ziegel reits Buy on Aradigm; target $9 (ARDM) 1.92 +0.06: Punk Ziegel reiterates their Buy rating and $9 target on ARDM, saying the stock represents an overlooked investment opportunity at its present $93 mln mkt cap; firm also cites the fact that pivotal studies for AERx Insulin are underway, continued clinical progress is being made for earlier-stage AERx and Intraject programs, and sees potential additional partner announcements for AERx and Intraject.<<

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News